Solchaga L A, Dennis J E, Goldberg V M, Caplan A I
Skeletal Research Center, Department of Biology, Case Western Reserve University, Cleveland, Ohio 44106-7080, USA.
J Orthop Res. 1999 Mar;17(2):205-13. doi: 10.1002/jor.1100170209.
Culture-expanded bone marrow-derived mesenchymal progenitor cells differentiate into chondrocytes or osteoblasts when implanted subcutaneously in vivo in combination with an appropriate delivery vehicle. This in vivo implantation technique is used to test new materials as putative delivery vehicles in skeletal tissue-engineering models. HYAFF 11 and ACP sponges, two biomaterials based on hyaluronic acid modified by esterification of the carboxyl groups of the glucuronic acid, were tested as osteogenic or chondrogenic delivery vehicles for rabbit mesenchymal progenitor cells and compared with a well characterized porous calcium phosphate ceramic delivery vehicle. The implant materials were examined by scanning electron microscopy for differences in pore structure or cellular interactions, were quantified for their ability to bind and retain mesenchymal progenitor cells, and were examined histologically for their ability to support osteogenesis and chondrogenesis after subcutaneous implantation into nude mice. The ACP sponge bound the same number of cells as fibronectin-coated ceramic, whereas the HYAFF 11 sponge bound 90% more. When coated with fibronectin, ACP and HYAFF 11 bound, respectively, 100 and 130% more cells than the coated ceramics. HYAFF 11 sponge composites retained their integrity after the 3 or 6-week incubation period in the animals and were processed for histomorphometric analysis. As a result of rapid degradation or resorption in vivo, ACP sponges could not be recovered after implantation and could not be analyzed. HYAFF 11 sponges presented more area available for cell attachment and more available volume for newly formed tissue. Following loading with mesenchymal progenitor cells and implantation, the pores of the sponges contained more bone and cartilage than the pores of ceramic cubes at either time point. Thus, relative to ceramic, HYAFF 11 sponges allow incorporation of twice as many cells and produce a 30% increase in the relative amount of bone and cartilage per unit area. Hence, the hyaluronic acid-based delivery vehicles are superior to porous calcium phosphate ceramic with respect to the number of cells loaded per unit volume of implant, and HYAFF 11 sponges are superior to the ceramics with regard to the amount of bone and cartilage formed. Additionally, hyaluronic acid-based vehicles have the advantage of degradation/resorption characteristics that allow complete replacement of the implant with newly formed tissue.
在体内与合适的递送载体联合皮下植入时,经培养扩增的骨髓间充质祖细胞可分化为软骨细胞或成骨细胞。这种体内植入技术用于在骨骼组织工程模型中测试作为假定递送载体的新材料。HYAFF 11和ACP海绵是两种基于对葡萄糖醛酸羧基进行酯化修饰的透明质酸的生物材料,被测试作为兔间充质祖细胞的成骨或成软骨递送载体,并与一种特征明确的多孔磷酸钙陶瓷递送载体进行比较。通过扫描电子显微镜检查植入材料的孔隙结构或细胞相互作用的差异,定量其结合和保留间充质祖细胞的能力,并通过组织学检查其在皮下植入裸鼠后支持成骨和成软骨的能力。ACP海绵结合的细胞数量与纤连蛋白包被的陶瓷相同,而HYAFF 11海绵结合的细胞数量多90%。当用纤连蛋白包被时,ACP和HYAFF 11分别比包被的陶瓷多结合100%和130%的细胞。在动物体内孵育3周或6周后,HYAFF 11海绵复合材料保持其完整性,并进行组织形态计量学分析。由于在体内快速降解或吸收,ACP海绵在植入后无法回收且无法分析。HYAFF 11海绵具有更多可用于细胞附着的面积和更多可用于新形成组织的体积。在加载间充质祖细胞并植入后,在两个时间点,海绵的孔隙中所含的骨和软骨均比陶瓷立方体的孔隙多。因此,相对于陶瓷,HYAFF 11海绵可容纳的细胞数量是其两倍,且单位面积内骨和软骨的相对量增加30%。因此,就每单位体积植入物加载的细胞数量而言,基于透明质酸的递送载体优于多孔磷酸钙陶瓷,就形成的骨和软骨量而言,HYAFF 11海绵优于陶瓷。此外,基于透明质酸的载体具有降解/吸收特性的优势,可使植入物完全被新形成的组织替代。